Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma

American Journal of Surgery

Volumn 192, Issue 1, 2006, Pages 29-33

  Park, Jung Ho ^a   Koh, Kwang Cheol ^a   Choi, Moon Suk ^a   Lee, Joon Hyoek ^a   Yoo, Byung Chul ^a   Paik, Seung Woon ^a   Rhee, Jong Chul ^a   Joh, Jae Won ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Intrahepatic metastases; Multinodular recurrence; Portal vein tumor thrombi

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY CANCER; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR EMBOLISM; TUMOR THROMBUS; TUMOR VOLUME; UNIVARIATE ANALYSIS;

CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33744942339     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2005.11.010     Document Type: Article

References (26)

1. Ahn S.H., Han K.H., Youn Y.H., et al. Risk factors for hepatocellular carcinoma in Korea. Korean J Intern Med 60 (2001) 123-130
2. Tung-Ping Poon R., Fan S.T., and Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232 (2000) 10-24
3. Matsumata T., Kanematsu T., Takenaka K., et al. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Hepatology 9 (1989) 457-460
4. Sonoyama T., Ochiai T., Hironaka T., et al. Predictors of postoperative diffuse intrahepatic recurrence of hepatocellular carcinoma. Hepatogastroenterology 50 (2003) 1078-1084
5. Poon R.T., Fan S.T., Ng I.O., et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89 (2000) 500-507
6. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatolo 38 (2003) 200-207
7. Makuuchi M., Belghiti J., Belli G., et al. IHPBA concordant classification of primary liver cancer. working group report. J Hepatobiliary Pancreat Surg 10 (2003) 26-30
8. Ueno S., Tanabe G., Sako K., et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 34 (2001) 529-534
9. Hui A.M., Takayama T., Sano K., et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 33 (2000) 975-979
10. Liver Cancer Study Group of Japan. The General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 4th ed (2000), Kanehara, Tokyo, Japan
11. Nakashima O., and Kojiro M. Recurrence of hepatocellular carcinoma. multicentric occurrence or intrahepatic metastases? A viewpoint in terms of pathology. J Hepatobiliary Pancreat Surg 8 (2001) 404-409
12. Belghiti J., Panis Y., Farges O., et al. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surgery 214 (1991) 114-117
13. Nagao T., Inoue S., Yoshimi F., et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211 (1990) 28-33
14. Shirabe K., Kanematsu T., Matsumata T., et al. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy. univariate and multivariate analyses. Hepatology 14 (1991) 802-805
15. Lai E.C., Ng I.O., Ng M.M., et al. Long-term results of resection for large hepatocellular carcinoma. a multivariate analysis of clinicopathological features. Hepatology 11 (1990) 815-818
16. Kaibori M., Matsui Y., Yanagida H., et al. Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin. important prognostic factor for recurrent hepatocellular carcinoma. World J Surg 28 (2004) 702-707
17. Adachi E., Maeda T., Matsumata T., et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108 (1995) 768-775
18. Hayashi T.Y.H., Ogawa Y., Sasaki K., et al. Prognostic factors of early recurrence after hepatic resection for hepatocellular carcinoma. J Jpn Soc Clin Surg 52 (1991) 1755-1761
19. Yamagata M., Maeda T., Ikeda Y., et al. Surgical results of spontaneously ruptured hepatocellular carcinoma. Hepatogastroenterology 42 (1995) 461-464
20. Shimada M., Takenaka K., Gion T., et al. Prognosis of recurrent hepatocellular carcinoma. a 10-year surgical experience in Japan. Gastroenterology 111 (1996) 720-726
21. Okamura J., Horikawa S., Fujiyama T., et al. An appraisal of transcatheter arterial embolization combined with transcatheter arterial infusion of chemotherapeutic agent for hepatic malignancies. World J Surg 6 (1982) 352-357
22. Sakurai M., Okamura J., and Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer 54 (1984) 387-392
23. Wu C.C., Ho Y.Z., Ho W.L., et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma. a reappraisal. Br J Surg 82 (1995) 122-126
24. Poon R.T., Ngan H., Lo C.M., et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73 (2000) 109-114
25. Izumi R., Shimizu K., Iyobe T., et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 20 (1994) 295-301
26. Tanaka K., Shimada H., Togo S., et al. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 46 (1999) 1083-1088